NOTE: Dataset members correspond to the amplicon sequence features; these can be used to retrieve associated constructs and stocks.

The TRiP-3 construct collection represents a second generation of TRiP lines. Each construct is designed to target the knockdown of a single gene during oogenesis using short hairpin RNA (shRNA).

Transgenic animals were designed to carry a short hairpin RNA (shRNA) under UAS-GAL4 control. To design the shRNA for any given gene, sequence for all exons, or all exon portions common to all transcripts, were reverse complemented and all possible 21-bp subsequences were determined. Sequences with off-target matches of 16-bp or more were discarded. The remaining sequences were scored as per Vert et al., 2006 (PMID: 17137497). Top and bottom strand oligonucleotides for the top scoring sequence were cloned into pVALIUM20, which by virture of it's hsp70 basal promoter, drives excellent knockdown in the soma and works well in the female germline. The hairpin-containing transgenes were inserted via site-specific recombination into genomic loci known to be optimal for expression, either the P{CaryP}attP2 or P{CaryP}attP40 target element.

shRNA sequences were predicted for all annotated genes, the vast majority using 'designer of small interfering RNA' (DSIR, Vert et al., 2006, PMID: 17137497). To minimize off­target effects, shRNAs whose guide or passenger strands had complementary matches of 16 nucleotides or more to the fly transcriptome. Only shRNAs that lacked sequence complementarity to annotated microRNA ‘seed’ sequences were considered. Hairpin constructs were based on the backbone of mir-1 with perfect complementarity between the guide and passenger strands, which favors loading onto AGO2 effector complexes. A shRNA library representing 83,256 unique synthetic hairpins was synthesized on four custom 22K Agilent microarrays, with up to six shRNAs per gene. Synthetic hairpin constructs were then amplified and cloned into pVALIUM20. The attB sequence allowed for targeted phiC31-mediated integration at genomic attP landing sites.